As of November 4, 2026, BioAtla, Inc. is a publicly traded company (OTC: BCAB). No bankruptcy or receivership appears in its SEC Form 8-K filings (RW, October 27, 2026).
Is this your company?
About to sign with, pay or invest in BioAtla, Inc.? See the free Snapshot first.
Free to see. No signup.
Is BioAtla, Inc. a real, registered company?
- BioAtla, Inc. files with the SEC under CIK 1826892 (its SEC filings).
- Its shares are listed under the ticker BCAB on OTC (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BioAtla, Inc. in our court records and SEC 8-K records (as of 2026-11-04).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-03-02).
- Leadership changes: the latest reported is Eric Sievers, Chief Medical Officer (Form 8-K filed 2026-09-29). Check you are dealing with the people now in charge.
Who are BioAtla, Inc.'s owners and officers?
BioAtla, Inc.: incorporated in Delaware; business address in San Diego, California; industry Biological Products, (No Diagnostic Substances) (RW, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2025-10-15 | Opoka Investment Fund Co | 4.8% |
Want the whole picture on BioAtla, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BioAtla, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BioAtla, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-29 | Eric Sievers | Chief Medical Officer | departed |
How much has BioAtla, Inc. raised?
Latest IPO step: BioAtla, Inc. withdrew its IPO registration (RW, 2026-10-27).
IPO filings: RW, 2026-10-27, S-1, 2026-10-20.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-03-02).
Keep reading
More on BioAtla, Inc. and the records around it.
BioAtla, Inc. elsewhere on the record
- Leadership changes Sep 2026
- Layoff notices Mar 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/bioatla